Much evidence have linked BMI1 to aggressive, malignant behavior, and poor clinical outcome in various cancer cells, including prostate cancer, breast cancer, lung cancer, ovarian cancer, and hepatocellular cancer [16–19]. The gene discussed is BMI1; the disease is prostate carcinoma.